Current indications and contraindications for transcatheter atrial septal defect and patent foramen ovale device closure
Open Access
- 1 April 2007
- journal article
- review article
- Published by Elsevier BV in American Heart Journal
- Vol. 153 (4), 81-84
- https://doi.org/10.1016/j.ahj.2007.01.011
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Migration of an Amplatzer Septal Occluder Device for Closure of Atrial Septal Defect into the Ascending Aorta With Formation of an Aorta-to-Right Atrial FistulaThe American Journal of Cardiology, 2005
- Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovaleInternational Journal of Cardiology, 2005
- Short- and intermediate-term results of transcatheter closure of atrial septal defect with the Amplatzer Septal OccluderAmerican Heart Journal, 2004
- Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic strokeJournal of the American College of Cardiology, 2004
- Successful treatment of left atrial disk thrombus on an Amplatzer atrial septal defect occluder with abciximab and heparinHeart, 2004
- Nickel release after implantation of the Amplatzer occluderAmerican Heart Journal, 2003
- Longevity in congenital heart disease: A tribute to pediatric cardiologyThe Journal of Pediatrics, 1993
- Patent foramen ovale: is stroke due to paradoxical embolism?Stroke, 1993
- Prevalence of Patent Foramen Ovale in Patients with StrokeNew England Journal of Medicine, 1988
- Atrioventricular septal defects: cross-sectional echocardiographic and morphologic comparisonsInternational Journal of Cardiology, 1986